Baxter 2021 Corporate Responsibility Report 36 Champion Our People and Communities Corporate Responsibility Commitment Introduction 2030 Corporate Responsibility Goals Empower Our Patients Protect Our Planet Appendix Cross-Cutting Commitments APPROACH AND PROGRESS Investing in our communities is central to our corporate responsibility approach. By pledging to contribute $275 million over the next 10 years, we aim to tackle some of the world’s toughest health and social challenges by leveraging our expertise and experience, as well as our employees’ passion to accelerate community-driven solutions alongside leading global partners. We cultivate innovative partnerships and catalyze positive impact in communities where our employees live and work, prioritizing social investments and solutions where we can make a meaningful difference. We engage three philanthropic channels to reach underserved communities, helping those with the least resources remove barriers to healthcare access. These include product donations and charitable giving from Baxter and the Baxter International Foundation (the Foundation). Product Donations Through Baxter’s product donations, we address unmet healthcare needs and improve health outcomes in un - derserved communities by supporting community-based health programs, medical missions and natural disaster preparedness and response efforts. To advance our commitment, we proactively build product donations into our corporate responsibility strategy by manufacturing products twice a year purposely for donation to our trusted humanitarian partners. This manufacture-to-donate strategy, an industry best practice, enables partners to rely on having Baxter’s critically needed, long-dated products available year-round—not solely during emergency situations —to help provide sustained support for underserved communities around the world. In 2021, we donated products valued at more than $36 million 1 through this program to Americares, Direct Relief and Partners In Health. We also continued to make chemotherapy drugs available through our U.S. Patient Assistance Program. This program supports cancer patients who have financial barriers to access and lack insurance or prescription drug coverage. 2030 CORPORATE RESPONSIBILITY GOAL : Invest $275 million in underserved communities through strategic partnerships and product donations from Baxter and the Baxter International Foundation. PERFORMANCE: In 2021, Baxter and the Baxter International Foundation invested nearly $52 million in underserved communities through strategic partnerships, grants and product donations . * By Baxter and the Baxter International Foundation. ** Through the Baxter Manufacture-to-Donate program. Value of products donated (provided at no cost) is provided by partners based on wholesale acquisition cost at the time of donation. This number may be greater or less than the value of Baxter products distributed during the year by our relief partners. HOW WE GIVE Product Donations Corporate Financial Contributions Baxter International Foundation Financial Contributions Manufacture-to-Donate program U.S. Patient Assistance Program Medical missions support Disaster relief donations Business and facility giving Charitable contributions to cultural and educational institutions, network memberships and healthcare organizations Value of Baxter employee volunteer time Signature Partnerships Grants for disaster relief and community, healthcare and STEM programs* Matching Gift and Dollars for Doers programs Global scholarships Prize programs Employee Disaster Relief Fund Invest in Underserved Communities Globally $52 million in cash and products contributed to communities worldwide* 94 countries reached through philanthropic giving* 8 Signature Partnerships supported $36 million + in products donated** * Contributions to U.S.-based 501(c)(3) organizations for programs within and outside of the United States. Champion Our People and Communities Corporate Responsibility Commitment Introduction 2030 Corporate Responsibility Goals Empower Our Patients Protect Our Planet Appendix Cross-Cutting Commitments
Baxter Corporate Responsibility Report Page 35 Page 37